News

All

category

2025.04.17

release

Announcement of Paper Publication: EditForce Demonstrated the Efficacy of a Treatment for Myotonic Dystrophy Type 1 Using PPR Platform Technology

2025.03.07

information

EditForce further elucidated the mechanism of RNA base editing by PPR proteins

2024.05.24

information

EditForce Made Poster Presentation at the Annual Meeting of American Society of Gene & Cell Therapy

2024.01.31

information

EditForce achieved selective enhancement of translation from target mRNA in human cells using programmable RNA-binding PPR proteins

2024.01.31

information

EditForce picked in "National Vision for Engineering Biology", published by UK Government

2023.10.19

information

EditForce Won Elsevier WMS Membership Award at World Muscle Society 2023

2023.09.16

information

EditForce Participated in Rett Syndrome Genetic Medicines Summit

2023.06.01

information

RELOCATION OF HEADQUARTERS

2023.05.22

release

COMPLETION OF FUND RAISING THROUGH THIRD-PARTY ALLOTMENT OF SHARES

2023.03.22

release

ADOPTION OF AMED STRENGTHENING PROGRAM FOR PHARMACEUTICAL STARTUP ECOSYSTEM

contact

Feel free to contact us when you have any questions or concerns.

Contact

PAGE TOP